Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Emily C. Dowling is active.

Publication


Featured researches published by Emily C. Dowling.


Cancer | 2013

Trends in Esophageal Adenocarcinoma Incidence and Mortality

Chin Hur; Melecia Miller; Chung Yin Kong; Emily C. Dowling; Kevin J. Nattinger; Michelle Dunn; Eric J. Feuer

Over the past several decades, the incidence of esophageal adenocarcinoma (EAC) has rapidly increased. The purpose of this analysis was to examine temporal trends in EAC incidence and mortality within the US population and, in addition, to explore these trends within subgroups of the population.


Journal of Clinical Oncology | 2013

Economic Burden of Cancer Survivorship Among Adults in the United States

Gery P. Guy; Donatus U. Ekwueme; K. Robin Yabroff; Emily C. Dowling; Chunyu Li; Juan L. Rodriguez; Janet S. de Moor; Katherine S. Virgo

PURPOSE To present nationally representative estimates of the impact of cancer survivorship on medical expenditures and lost productivity among adults in the United States. METHODS Using the 2008 to 2010 Medical Expenditure Panel Survey, we identified 4,960 cancer survivors and 64,431 individuals without a history of cancer age ≥ 18 years. Direct medical costs were measured using annual health care expenditures and examined by source of payment and service type. Indirect morbidity costs were estimated from lost productivity as a result of employment disability, missed work days, and lost household productivity. We evaluated the economic burden of cancer survivorship by estimating excess costs among cancer survivors, stratified by time since diagnosis (recently diagnosed [≤ 1 year] and previously diagnosed [> 1 year]), compared with individuals without a history of cancer using multivariable regression models stratified by age (18 to 64 and ≥ 65 years), controlling for age, sex, race/ethnicity, education, and comorbidities. RESULTS In 2008 to 2010, the annual excess economic burden of cancer survivorship among recently diagnosed cancer survivors was


Journal of Medical Screening | 2010

Breast and cervical cancer screening programme implementation in 16 countries

Emily C. Dowling; Carrie N. Klabunde; Julietta Patnick; Rachel Ballard-Barbash

16,213 per survivor age 18 to 64 years and


Journal of Clinical Oncology | 2016

Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors

K. Robin Yabroff; Emily C. Dowling; Gery P. Guy; Matthew P. Banegas; Amy J. Davidoff; Xuesong Han; Katherine S. Virgo; Timothy S. McNeel; Neetu Chawla; Danielle Blanch-Hartigan; Erin E. Kent; Chunyu Li; Juan L. Rodriguez; Janet S. de Moor; Zhiyuan Zheng; Ahmedin Jemal; Donatus U. Ekwueme

16,441 per survivor age ≥ 65 years. Among previously diagnosed cancer survivors, the annual excess burden was


Cancer | 2013

Lost productivity and burden of illness in cancer survivors with and without other chronic conditions.

Emily C. Dowling; Neetu Chawla; Laura P. Forsythe; Janet S. de Moor; Timothy S. McNeel; Heather M. Rozjabek; Donatus U. Ekwueme; K. Robin Yabroff

4,427 per survivor age 18 to 64 years and


Cancer | 2010

Burden of Illness in Adult Survivors of Childhood Cancers: Findings from a Population-based National Sample

Emily C. Dowling; K. Robin Yabroff; Angela B. Mariotto; Timothy S. McNeel; Christopher Zeruto; Dennis W. Buckman

4,519 per survivor age ≥ 65 years. Excess medical expenditures composed the largest share of the economic burden among cancer survivors, particularly among those recently diagnosed. CONCLUSION The economic impact of cancer survivorship is considerable and is also high years after a cancer diagnosis. Efforts to reduce the economic burden caused by cancer will be increasingly important given the growing population of cancer survivors.


Journal of Cancer Survivorship | 2012

The Medical Expenditure Panel Survey (MEPS) Experiences with Cancer Survivorship Supplement

K. Robin Yabroff; Emily C. Dowling; Juan L. Rodriguez; Donatus U. Ekwueme; Helen I. Meissner; Anita Soni; Catherine Lerro; Gordon Willis; Laura P. Forsythe; Laurel Borowski; Katherine S. Virgo

Objective There is a continuing need to monitor and evaluate the impact of organized screening programmes on cancer incidence and mortality. We report results from a programme assessment conducted within the International Cancer Screening Network (ICSN) to understand the characteristics of cervical screening programmes within countries that have established population-based breast cancer screening programmes. Methods In 2007-2008, we asked 26 ICSN country representatives to complete a web-based survey that included questions on breast and cervical cancer screening programmes. We summarized information from 16 countries with both types of organized programmes. Results In 63% of these countries, the organization of the cervical cancer screening programme was similar to that of the breast cancer screening programme in the same country. There were differences in programme characteristics, including year established (1962-2003 cervical; 1986-2002 breast) and ages covered (15-70+ cervical; 40-75+ breast). Adoption of new screening technologies was evident (44% liquid-based Pap tests; 13% human papillomavirus (HPV)-triage tests cervical; 56% digital mammography breast). There was wide variation in participation rates for both programme types (<4-80% cervical; 12-88% breast), and participation rates tended to be higher for cervical (70-80%) than for breast (60-70%) cancer screening programmes. Eleven ICSN member countries had approved the HPV vaccine and five more were considering its use in their organized programmes. Conclusion Overall, there were similarities and differences in the organization of breast and cervical cancer screening programmes among ICSN countries. This assessment can assist established and new screening programmes in understanding the organization and structure of cancer screening programmes.


Medical Care | 2014

ANNUAL PATIENT TIME COSTS ASSOCIATED WITH MEDICAL CARE AMONG CANCER SURVIVORS IN THE UNITED STATES

K. Robin Yabroff; Gery P. Guy; Donatus U. Ekwueme; Timothy S. McNeel; Heather M. Rozjabek; Emily C. Dowling; Chunyu Li; Katherine S. Virgo

PURPOSE To estimate the prevalence of financial hardship associated with cancer in the United States and identify characteristics of cancer survivors associated with financial hardship. METHODS We identified 1,202 adult cancer survivors diagnosed or treated at ≥ 18 years of age from the 2011 Medical Expenditure Panel Survey Experiences With Cancer questionnaire. Material financial hardship was measured by ever (1) borrowing money or going into debt, (2) filing for bankruptcy, (3) being unable to cover ones share of medical care costs, or (4) making other financial sacrifices because of cancer, its treatment, and lasting effects of treatment. Psychological financial hardship was measured as ever worrying about paying large medical bills. We examined factors associated with any material or psychological financial hardship using separate multivariable logistic regression models stratified by age group (18 to 64 and ≥ 65 years). RESULTS Material financial hardship was more common in cancer survivors age 18 to 64 years than in those ≥ 65 years of age (28.4% v 13.8%; P < .001), as was psychological financial hardship (31.9% v 14.7%, P < .001). In adjusted analyses, cancer survivors age 18 to 64 years who were younger, female, nonwhite, and treated more recently and who had changed employment because of cancer were significantly more likely to report any material financial hardship. Cancer survivors who were uninsured, had lower family income, and were treated more recently were more likely to report psychological financial hardship. Among cancer survivors ≥ 65 years of age, those who were younger were more likely to report any financial hardship. CONCLUSION Cancer survivors, especially the working-age population, commonly experience material and psychological financial hardship.


American Journal of Preventive Medicine | 2013

Access to Preventive Health Care for Cancer Survivors

K. Robin Yabroff; Pamela Farley Short; Steven R. Machlin; Emily C. Dowling; Heather M. Rozjabek; Chunyu Li; Timothy S. McNeel; Donatus U. Ekwueme; Katherine S. Virgo

Cancer survivors may experience long‐term and late effects from treatment that adversely affect health and limit functioning. Few studies examine lost productivity and disease burden in cancer survivors compared with individuals who have other chronic conditions or by cancer type.


Archive | 2010

Obesity and Cancer Epidemiology

Rachel Ballard-Barbash; David Berrigan; Nancy Potischman; Emily C. Dowling

The number of adult survivors of childhood cancer in the United States is increasing because of effective treatments and improved survival. The purpose of this study was to use a national, population‐based sample to estimate the burden of illness in adult survivors of childhood cancer.

Collaboration


Dive into the Emily C. Dowling's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Donatus U. Ekwueme

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

K. Robin Yabroff

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gery P. Guy

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Chunyu Li

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge